In the news release, Infinity To Present At Cantor Fitzgerald
Global Healthcare Conference, issued 26-Sep-2018 by Infinity Pharmaceuticals, Inc.
over PR Newswire, we are advised by the company that the
presentation date and time for the Cantor Fitzgerald Global
Healthcare Conference have been updated. The complete, corrected
release follows:
Infinity To Present At Cantor Fitzgerald Global Healthcare
Conference
CAMBRIDGE, Mass., Sept. 26, 2018 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at Cantor
Fitzgerald's Global Healthcare Conference on Tuesday, October 2, 2018, at 5:10 p.m. ET at the Intercontinental New York
Barclay Hotel in New York, NY. A
live webcast of the presentation will be available on the
Investors/Media section of Infinity's website at www.infi.com, and
will be available for 30 days following the event.
About Infinity
Infinity is an innovative biopharmaceutical company dedicated to
advancing novel cancer treatments. Infinity is advancing IPI-549, a
potentially transformative immuno-oncology approach that aims to
reprogram tumor-associated macrophages by selectively inhibiting
PI3K-gamma. A Phase 1/1b study in
approximately 200 patients with advanced solid tumors is ongoing.
For more information on Infinity, please refer to Infinity's
website at www.infi.com.
Contact:
Stephanie
Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com
View original
content:http://www.prnewswire.com/news-releases/infinity-to-present-at-cantor-fitzgerald-global-healthcare-conference-300719031.html
SOURCE Infinity Pharmaceuticals, Inc.